We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+12.89%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$245M
AUM Growth
+$12.8M
Cap. Flow
-$9.76M
Cap. Flow %
-3.98%
Top 10 Hldgs %
37.52%
Holding
47
New
9
Increased
11
Reduced
14
Closed
9

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$6.14M
2
THC icon
Tenet Healthcare
THC
+$5.49M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.4M
4
INCY icon
Incyte
INCY
+$5.19M
5
CAH icon
Cardinal Health
CAH
+$5.19M

Top Sells

Rank Stock Value
1
PPD
PPD, Inc. Common Stock
PPD
+$7.4M
2
COR icon
Cencora
COR
+$5.82M
3
DGX icon
Quest Diagnostics
DGX
+$5.72M
4
MRK icon
Merck
MRK
+$4.98M
5
LHCG
LHC Group LLC
LHCG
+$3.72M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$625B
$10.2M 4.17%
65,000
+5,000
+8% +$738K
HCA icon
2
HCA Healthcare
HCA
$89.5B
$9.87M 4.02%
60,000
– –
REGN icon
3
Regeneron Pharmaceuticals
REGN
$80.8B
$9.66M 3.94%
20,000
+10,000
+100% +$5.4M
MCK icon
4
McKesson
MCK
$101B
$9.57M 3.9%
55,000
+2,500
+5% +$416K
MDT icon
5
Medtronic
MDT
$112B
$9.37M 3.82%
80,000
+10,000
+14% +$1.1M
ZBH icon
6
Zimmer Biomet
ZBH
$18.4B
$9.24M 3.77%
61,800
+5,150
+9% +$727K
UHS icon
7
Universal Health Services
UHS
$10.5B
$8.94M 3.64%
65,000
– –
DHR icon
8
Danaher
DHR
$144B
$8.89M 3.62%
45,120
-5,640
-11% -$1.13M
ABT icon
9
Abbott
ABT
$187B
$8.21M 3.35%
75,000
-15,000
-17% -$1.63M
IQV icon
10
IQVIA
IQV
$39.3B
$8.06M 3.29%
45,000
+15,000
+50% +$2.53M
SYK icon
11
Stryker
SYK
$130B
$7.35M 3%
30,000
– –
BSX icon
12
Boston Scientific
BSX
$71.5B
$7.19M 2.93%
200,000
+30,000
+18% +$1.08M
HUM icon
13
Humana
HUM
$46.2B
$7.18M 2.93%
17,500
-2,500
-13% -$1.04M
AVTR icon
14
Avantor
AVTR
$9.19B
$7.04M 2.87%
250,000
– –
BMRN icon
15
BioMarin Pharmaceuticals
BMRN
$12.4B
$7.01M 2.86%
80,000
+15,000
+23% +$1.19M
UNH icon
16
UnitedHealth
UNH
$370B
$7.01M 2.86%
20,000
-2,000
-9% -$670K
TMO icon
17
Thermo Fisher Scientific
TMO
$220B
$6.99M 2.85%
15,000
-5,000
-25% -$2.34M
MOH icon
18
Molina Healthcare
MOH
$10.3B
$6.91M 2.82%
32,500
-12,500
-28% -$2.58M
BDX icon
19
Becton Dickinson
BDX
$48.2B
$6.88M 2.81%
28,188
+11,788
+72% +$2.75M
THC icon
20
Tenet Healthcare
THC
$21.1B
$6.79M 2.77%
+170,000
New +$5.49M
LH icon
21
Labcorp
LH
$25.9B
$6.62M 2.7%
37,830
-8,730
-19% -$1.51M
ELV icon
22
Elevance Health
ELV
$85.5B
$6.42M 2.62%
+20,000
New +$6.14M
BAX icon
23
Baxter International
BAX
$14.2B
$6.02M 2.45%
75,000
-10,000
-12% -$792K
LLY icon
24
Eli Lilly
LLY
$1.06T
$5.91M 2.41%
35,000
-20,000
-36% -$2.99M
GH icon
25
Guardant Health
GH
$22.6B
$5.8M 2.36%
45,000
+10,000
+29% +$1.15M
1
2

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
A
AFBI Miami Beach, Florida $131M AUM
SPWM
Schrum Private Wealth Management St. Augustine, Florida $131M AUM 18.38% 1-Year Est. Return

Sivik Global Healthcare's Q4 2020 Portfolio in Review

As of Q4 2020, Sivik Global Healthcare held 47 positions worth $245M, up 5.5% from $232M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Sivik Global Healthcare withdrew a net $9.76M in Q4 2020, closing 9 positions and reducing 14 holdings. Its most notable exit was PPD, Inc. Common Stock, an estimated $7.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 98% a quarter earlier, followed by Energy.

Against the trend, Sivik Global Healthcare opened a new position in Elevance Health worth $6.42M.

  • Sivik Global Healthcare's largest Q4 2020 buy was Elevance Health: 20,000 shares worth $6.42M.
  • Sivik Global Healthcare added most to Regeneron Pharmaceuticals in Q4 2020, an estimated $5.4M increase.
  • Sivik Global Healthcare's biggest Q4 2020 reduction was CATALENT, INC., cutting an estimated $3.63M.
  • Sivik Global Healthcare fully exited PPD, Inc. Common Stock in Q4 2020, selling an estimated $7.4M.
  • Sivik Global Healthcare's ten largest holdings make up 38% of its $245M portfolio in Q4 2020.
  • Sivik Global Healthcare opened 9 new positions and closed 9 in Q4 2020.
  • Sivik Global Healthcare's portfolio value rose 5.5% quarter-over-quarter to $245M.

Based on Sivik Global Healthcare's 13F filing for Q4 2020, filed 16 Feb 2021.